Functional silencing of HSD17B2 in prostate cancer promotes disease progression.

CONCLUSION: Our findings provide evidence of the clinical relevance, significance and regulation of HSD17B2 in prostate cancer progression, which might provide new strategies for clinical management by targeting the functional silencing mechanisms of HSD17B2.
PMID: 30228209 [PubMed - as supplied by publisher]

Source: Clinical Cancer Research - September 18, 2018 Category: Cancer & Oncology Authors: Gao X, Dai C, Huang S, Tang J, Chen G, Li J, Zhu Z, Zhu X, Zhou S, Gao Y, Hou Z, Fang Z, Xu C, Wang J, Wu D, Sharifi N, Li Z Tags: Clin Cancer Res Source Type: research